Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-30 11:23 am Purchase | 2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Farallon Capital Partners, L.P. | 2,205,990 9.990% | 788,073 (+55.58%) | Filing History |
| 2024-01-29 5:01 pm Sale | 2024-01-25 | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 0 0.000% | -3,978,540 (Position Closed) | Filing History |
| 2024-01-26 4:19 pm Sale | 2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Integrated Core Strategies (US) LLC | 6,610 0.000% | -981,102 (-99.33%) | Filing History |
| 2024-01-12 5:00 pm Purchase | 2024-01-02 | 13G | Longboard Pharmaceuticals, Inc. LBPH | RA Capital Management, L.P. | 3,073,119 8.700% | 3,073,119 (New Position) | Filing History |
| 2024-01-10 4:12 pm Unchanged | 2024-01-08 | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 3,978,540 11.260% | 0 (Unchanged) | Filing History |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Longboard Pharmaceuticals, Inc. LBPH | FMR LLC | 1,947,316 9.472% | -953,076 (-32.86%) | Filing History |
| 2023-04-19 9:48 pm Purchase | 2023-04-12 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Prosight Management LP | 948,012 4.900% | 948,012 (New Position) | Filing History |
| 2023-03-27 4:27 pm Unchanged | 2023-02-07 | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 3,978,540 17.300% | 0 (Unchanged) | Filing History |
| 2023-03-10 09:30 am Purchase | 2023-03-09 | 13G | Longboard Pharmaceuticals, Inc. LBPH | FMR LLC | 2,900,392 14.999% | 1,795,488 (+162.50%) | Filing History |
| 2023-02-14 4:01 pm Purchase | 2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | HBM Healthcare Investments (Cayman) Ltd. | 1,345,009 9.990% | 17,579 (+1.32%) | Filing History |
| 2023-02-14 3:05 pm Purchase | 2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management LP | 1,801,947 9.990% | 420,015 (+30.39%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | T. Rowe Price Associates, Inc. | 1,510,961 11.100% | -513,655 (-25.37%) | Filing History |
| 2023-02-13 8:33 pm Purchase | 2023-02-10 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Point72 Asset Management, L.P. | 1,250,000 6.500% | 1,250,000 (New Position) | Filing History |
| 2023-02-09 12:48 pm Sale | 2023-02-09 | 13G | Longboard Pharmaceuticals, Inc. LBPH | FMR LLC | 1,104,904 8.132% | -410,678 (-27.10%) | Filing History |
| 2023-02-03 5:15 pm Purchase | 2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Farallon Capital Partners, L.P. | 1,417,917 9.990% | 1,417,917 (New Position) | Filing History |
| 2023-01-25 4:38 pm Purchase | 2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Integrated Core Strategies (US) LLC | 987,712 7.300% | 212,232 (+27.37%) | Filing History |
| 2022-03-21 4:25 pm Purchase | 2022-03-11 | 13D | Longboard Pharmaceuticals, Inc. LBPH | PFIZER INC PFE | 3,978,540 23.100% | 3,978,540 (New Position) | Filing History |
| 2022-03-10 4:43 pm Purchase | 2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | ARENA PHARMACEUTICALS INC ARNA | 3,978,540 23.100% | 3,978,540 (New Position) | Filing History |
| 2022-02-14 3:16 pm Purchase | 2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management LP | 1,381,932 9.990% | 42,301 (+3.16%) | Filing History |
| 2022-02-14 2:35 pm Sale | 2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | T. Rowe Price Associates, Inc. | 2,024,616 14.900% | -278,133 (-12.08%) | Filing History |